SeaCrest Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026SeaCrest Wealth Management, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $46.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$46.0M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 13,787 | $12.7M |
| JNJJOHNSON & JOHNSON | 22,889 | $5.6M |
| AMGNAMGEN INC | 14,480 | $5.1M |
| MRKMerck & Co., Inc. | 34,568 | $4.2M |
| ABBVAbbVie Inc. | 13,191 | $2.9M |
| PMPhilip Morris International Inc | 15,249 | $2.5M |
| PFEPFIZER INC | 72,067 | $2.0M |
| MCKMcKesson Corporation | 2,306 | $2.0M |
| TEVATeva Pharmaceutical Industries Limited | 54,814 | $1.7M |
| AZNASTRAZENECA PLC | 6,960 | $1.4M |
| ABTABBOTT LABORATORIES | 11,116 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 16,021 | $972K |
| GILDGILEAD SCIENCES, INC. | 6,446 | $898K |
| CAHCardinal Health Inc. | 3,143 | $664K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,080 | $563K |
| NVONovo Nordisk A/S | 14,486 | $532K |
| ELVElevance Health Inc. | 1,267 | $371K |
| DGXQuest Diagnostics Incorporated | 1,668 | $327K |
| GMOptec International, Inc. | 3,843 | $286K |
| SNYSanofi | 5,167 | $249K |
| CLOVClover Health Investments Corp. | 41,100 | $72K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.